Clinical trials
Recruiting Diabetes Mellitus, Type 2 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
101 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2021 | 3 |
| 2022 | 7 |
| 2023 | 6 |
| 2024 | 14 |
| 2025 | 31 |
| 2026 | 32 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 101 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 8 |
| Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 5 |
| The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 5 |
| Nanjing First Hospital, Nanjing Medical University | 4 |
| Shanghai 6th People's Hospital | 4 |
| The United Bio-Technology (Hengqin) Co., Ltd. | 3 |
| Fujian Shengdi Pharmaceutical Co., Ltd. | 2 |
| Hoffmann-La Roche | 2 |
| Qilu Hospital of Shandong University | 2 |
| Second Xiangya Hospital of Central South University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 101 |
| Obesity | 12 |
| Cognitive Dysfunction | 8 |
| Overweight | 8 |
| Cardiovascular Diseases | 6 |
| Diabetes Mellitus | 6 |
| Metabolic Syndrome | 4 |
| Renal Insufficiency, Chronic | 4 |
| Coronary Artery Disease | 3 |
| Diabetic Retinopathy | 3 |
Trials
Showing 1 to 25 of 101. Each trial links to its page on Pharma Observatory.
1 more trial matches. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.